Alcon Inc (ALC) reports a 5% increase in revenue, driven by robust performance in surgical and ocular health segments, despite facing margin challenges and tariff-related costs.
Q3 2025 Management View CEO David Endicott pointed to building momentum in the second half of 2025, with particular strength in equipment and ocular health. Endicott highlighted, "the launch [of Unity ...
The global eyecare company, with manufacturing and research facilities in Berks County, reduced its full-year projections in ...
ALC delivered third-quarter 2025 core earnings per share (EPS) of 79 cents, down 2.5% from the year-ago quarter’s figure. At ...
Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum ...